Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.74 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Isobutyl Ketone SCHEMBL27928005 | 0.89 | ALDH1A1 (0.82) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| Methyl Isobutyl Ketone SCHEMBL15458 | 0.86 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL1580340 | 0.86 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL1128055 | 0.86 | ALDH1A1 (1.00) | ALDH1A1TDP1CA2CYP2C19SMN1; SMN2 | |
| Methyl Isobutyl Ketone SCHEMBL842835 | 0.83 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL358566 | 0.83 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL809423 | 0.83 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL2188913 | 0.83 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL8421472 | 0.83 | — | — | |
| Methyl Isobutyl Ketone SCHEMBL7073455 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10961250-B2 | Short-acting benzodiazepine salts and their polymorphic forms | PAION UK LIMITED (GB) | 2021-03-30 | — | — | US | disclosed |
| US-20200130362-A1 | POROUS BODY, METHOD OF PRODUCING POROUS BODY AND INK JET RECORDING METHOD | CANON KABUSHIKI KAISHA (JP) | 2020-04-30 | — | — | US | disclosed |
| US-20200070519-A1 | METHOD FOR PRODUCING POROUS BODY, POROUS BODY, AND INKJET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2020-03-05 | — | — | US | disclosed |
| US-20200039990-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | PAION UK LIMITED (GB) | 2020-02-06 | — | — | US | disclosed |
| US-10472365-B2 | Short-acting benzodiazepine salts and their polymorphic forms | PAION UK LIMITED (GB) | 2019-11-12 | — | — | US | disclosed |
| US-20180186803-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | PAION UK LIMITED (GB) | 2018-07-05 | — | — | US | disclosed |
| US-9777007-B2 | Short-acting benzodiazepine salts and their polymorphic forms | PAION UK LIMITED (GB) | 2017-10-03 | — | — | US | disclosed |
| US-20160176881-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | PAION UK LIMITED (GB) | 2016-06-23 | — | — | US | disclosed |
| US-9193730-B2 | Short-acting benzodiazepine salts and their polymorphic forms | PAION UK LIMITED (GB) | 2015-11-24 | — | — | US | disclosed |
| EP-2081921-B1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | PAION UK LTD (GB) | 2010-09-08 | — | — | EP | disclosed |
| US-20100081647-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | PAION UK LIMITED (GB) | 2010-04-01 | — | — | US | disclosed |
| EP-2081921-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | PAION UK Limited (GB) | 2009-07-29 | — | — | EP | disclosed |
| WO-2008007071-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | CENES LIMITED (GB) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160176881-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | GABRA5, GABRA6, GABRA1 | ALDH1A1 646/4885TDP1 2603/4885CA2 869/4885 |
| US-10472365-B2 | Short-acting benzodiazepine salts and their polymorphic forms | GABRA5, GABRA6, GABRA1 | ALDH1A1 646/4885TDP1 2603/4885CA2 869/4885 |
| US-20180186803-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | GABRA5, GABRA6, GABRA1 | ALDH1A1 646/4885TDP1 2603/4885CA2 869/4885 |
| US-20100081647-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | GABRA5, GABRA6, GABRA1 | ALDH1A1 646/4885TDP1 2603/4885CA2 869/4885 |
| US-20200039990-A1 | SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS | GABRA5, GABRA6, GABRA1 | ALDH1A1 646/4885TDP1 2603/4885CA2 869/4885 |
| US-10961250-B2 | Short-acting benzodiazepine salts and their polymorphic forms | GABRA5, GABRA6, GABRA1 | ALDH1A1 646/4885TDP1 2603/4885CA2 869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.